RATIONALE: Cardiac CITED4 (CBP/p300-interacting transactivators with E [glutamic acid]/D [aspartic acid]-rich-carboxylterminal domain4) is induced by exercise and is sufficient to cause physiological hypertrophy and mitigate adverse ventricular remodeling after ischemic injury. However, the role of endogenous CITED4 in response to physiological or pathological stress is unknown. OBJECTIVE: To investigate the role of CITED4 in murine models of exercise and pressure overload. METHODS AND RESULTS: We generated cardiomyocyte-specific CITED4 knockout mice (C4KO) and subjected them to an intensive swim exercise protocol as well as transverse aortic constriction (TAC). Echocardiography, Western blotting, qPCR, immunohistochemistry, immunofluorescence, and transcriptional profiling for mRNA and miRNA (microRNA) expression were performed. Cellular crosstalk was investigated in vitro. CITED4 deletion in cardiomyocytes did not affect baseline cardiac size or function in young adult mice. C4KO mice developed modest cardiac dysfunction and dilation in response to exercise. After TAC, C4KOs developed severe heart failure with left ventricular dilation, impaired cardiomyocyte growth accompanied by reduced mTOR (mammalian target of rapamycin) activity and maladaptive cardiac remodeling with increased apoptosis, autophagy, and impaired mitochondrial signaling. Interstitial fibrosis was markedly increased in C4KO hearts after TAC. RNAseq revealed induction of a profibrotic miRNA network. miR30d was decreased in C4KO hearts after TAC and mediated crosstalk between cardiomyocytes and fibroblasts to modulate fibrosis. miR30d inhibition was sufficient to increase cardiac dysfunction and fibrosis after TAC. CONCLUSIONS: CITED4 protects against pathological cardiac remodeling by regulating mTOR activity and a network of miRNAs mediating cardiomyocyte to fibroblast crosstalk. Our findings highlight the importance of CITED4 in response to both physiological and pathological stimuli.
RATIONALE: Cardiac CITED4 (CBP/p300-interacting transactivators with E [glutamic acid]/D [aspartic acid]-rich-carboxylterminal domain4) is induced by exercise and is sufficient to cause physiological hypertrophy and mitigate adverse ventricular remodeling after ischemic injury. However, the role of endogenous CITED4 in response to physiological or pathological stress is unknown. OBJECTIVE: To investigate the role of CITED4 in murine models of exercise and pressure overload. METHODS AND RESULTS: We generated cardiomyocyte-specific CITED4 knockout mice (C4KO) and subjected them to an intensive swim exercise protocol as well as transverse aortic constriction (TAC). Echocardiography, Western blotting, qPCR, immunohistochemistry, immunofluorescence, and transcriptional profiling for mRNA and miRNA (microRNA) expression were performed. Cellular crosstalk was investigated in vitro. CITED4 deletion in cardiomyocytes did not affect baseline cardiac size or function in young adult mice. C4KO mice developed modest cardiac dysfunction and dilation in response to exercise. After TAC, C4KOs developed severe heart failure with left ventricular dilation, impaired cardiomyocyte growth accompanied by reduced mTOR (mammalian target of rapamycin) activity and maladaptive cardiac remodeling with increased apoptosis, autophagy, and impaired mitochondrial signaling. Interstitial fibrosis was markedly increased in C4KO hearts after TAC. RNAseq revealed induction of a profibrotic miRNA network. miR30d was decreased in C4KO hearts after TAC and mediated crosstalk between cardiomyocytes and fibroblasts to modulate fibrosis. miR30d inhibition was sufficient to increase cardiac dysfunction and fibrosis after TAC. CONCLUSIONS: CITED4 protects against pathological cardiac remodeling by regulating mTOR activity and a network of miRNAs mediating cardiomyocyte to fibroblast crosstalk. Our findings highlight the importance of CITED4 in response to both physiological and pathological stimuli.
Entities:
Keywords:
exercise; extracellular matrix; heart failure; signal transduction
Authors: Philipp Mertins; Namrata D Udeshi; Karl R Clauser; D R Mani; Jinal Patel; Shao-en Ong; Jacob D Jaffe; Steven A Carr Journal: Mol Cell Proteomics Date: 2011-12-30 Impact factor: 5.911
Authors: T Yahata; M P de Caestecker; R J Lechleider; S Andriole; A B Roberts; K J Isselbacher; T Shioda Journal: J Biol Chem Date: 2000-03-24 Impact factor: 5.157
Authors: Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth Journal: Nucleic Acids Res Date: 2015-01-20 Impact factor: 16.971
Authors: Ashish Yeri; Amanda Courtright; Kirsty Danielson; Elizabeth Hutchins; Eric Alsop; Elizabeth Carlson; Michael Hsieh; Olivia Ziegler; Avash Das; Ravi V Shah; Joel Rozowsky; Saumya Das; Kendall Van Keuren-Jensen Journal: BMC Genomics Date: 2018-05-05 Impact factor: 3.969
Authors: Carolin Lerchenmüller; Ana Vujic; Anthony Rosenzweig; Richard T Lee; Sonja Mittag; Annie Wang; Charles P Rabolli; Chiara Heß; Fynn Betge; Ashraf Y Rangrez; Malay Chaklader; Christelle Guillermier; Frank Gyngard; Jason D Roh; Haobo Li; Matthew L Steinhauser; Norbert Frey; Beverly Rothermel; Christoph Dieterich Journal: Circulation Date: 2022-07-06 Impact factor: 39.918
Authors: Margaret H Hastings; Jonathan J Herrera; J Sawalla Guseh; Bjarni Atlason; Nicholas E Houstis; Azrul Abdul Kadir; Haobo Li; Cedric Sheffield; Anand P Singh; Jason D Roh; Sharlene M Day; Anthony Rosenzweig Journal: Circ Res Date: 2022-06-09 Impact factor: 23.213
Authors: Robert A Eder; Maaike van den Boomen; Salva R Yurista; Yaiel G Rodriguez-Aviles; Mohammad Rashedul Islam; Yin-Ching Iris Chen; Lena Trager; Jaume Coll-Font; Leo Cheng; Haobo Li; Anthony Rosenzweig; Christiane D Wrann; Christopher T Nguyen Journal: Commun Biol Date: 2022-07-04
Authors: Nor Hidayah Mustafa; Juriyati Jalil; Satirah Zainalabidin; Mohammed S M Saleh; Ahmad Yusof Asmadi; Yusof Kamisah Journal: Front Pharmacol Date: 2022-08-08 Impact factor: 5.988
Authors: Kirsten T Nijholt; Pablo I Sánchez-Aguilera; Suzanne N Voorrips; Rudolf A de Boer; B Daan Westenbrink Journal: Eur J Heart Fail Date: 2022-01-09 Impact factor: 17.349